2m 2m 2m 2m 2m 2m 2m
Jrsis Health (JRSS)
OTC
$0.13+$0.04 (+44.44%)
Price as of Jun 03, 2026- $5.2MMarket Cap
- 480.36%1-Year Change
- Specialty RetailIndustry
Jrsis Health (JRSS)
$0.13+$0.04 (+44.44%)
Annual
Quarterly
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.5M +3,782.57% | 89,166 -99.80% | 44.4M +24.32% | 35.7M N/A | |
Cost of Revenue | 3.0M +617.71% | 415,055 -98.97% | 40.3M +33.79% | 30.1M N/A | |
Gross Profit | 483,051 +248.23% | -325,889 -107.94% | 4.1M -26.64% | 5.6M N/A | |
Sales and Marketing Expense | 146,334 N/A | N/A N/A | 35,817 N/A | N/A N/A | |
Research and Development Expense | -189,266 N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 53,815 +828.49% | 5,796 -99.83% | 3.3M +22.91% | 2.7M N/A | |
Total Operating Expenses | 671,649 +61.82% | 415,055 -98.97% | 40.3M +33.79% | 30.1M N/A | |
Operating Profit | -188,598 -42.13% | -325,889 -107.94% | 4.1M -26.64% | 5.6M N/A | |
Interest Income | 3,058 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -56,443 N/A | N/A N/A | -1.4M +21.48% | -1.1M N/A | |
Interest Income and Expense and Net | -53,385 N/A | 0 +100.00% | -1.4M +21.48% | -1.1M N/A | |
Total Nonoperating Income and Expense | 102,985 +6,015.28% | -1,741 -100.65% | 266,957 +167.33% | -396,497 N/A | |
Income before Taxes | -85,613 -73.87% | -327,630 -107.50% | 4.4M -15.91% | 5.2M N/A | |
Income Taxes | 8,975 N/A | N/A N/A | 1.2M -13.76% | 1.4M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -80,912 -99.76% | -33.7M -1,157.44% | 3.2M +19.03% | 2.7M N/A | |
Net Income from Continuing Operations Applicable to Common | -85,613 -73.87% | -327,630 -114.68% | 2.2M -57.05% | 5.2M N/A | |
Basic EPS and Net Income | -0.001 -99.87% | -0.75 -720.91% | 0.12 -18.41% | 0.15 N/A | |
Diluted EPS and Net Income | -0.001 -99.87% | -0.75 -728.18% | 0.12 -18.42% | 0.15 N/A | |
Basic Weighted Average Shares | 77.3M +72.11% | 44.9M +143.26% | 18.5M +2.17% | 18.1M N/A | |
Diluted Weighted Average Shares | 77.3M +72.11% | 44.9M +140.52% | 18.7M +2.14% | 18.3M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 118,114 +101.50% | 58,616 -93.15% | 855,971 +1.32% | 844,827 N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 118,114 +101.50% | 58,616 -93.15% | 855,971 +1.32% | 844,827 N/A | |
Total Current Assets | 1.8M +129.57% | 798,850 -94.24% | 13.9M +75.99% | 7.9M N/A | |
Accumulated Depreciation | 97,552 +1,625.06% | 5,655 -99.96% | 13.7M +34.17% | 10.2M N/A | |
Property and Plant and Equipment and Net | 50,024 +28.30% | 38,989 -99.88% | 33.2M +5.43% | 31.5M N/A | |
Total Long-Term Assets | 310,635 +696.72% | 38,989 -99.89% | 35.3M +3.87% | 34.0M N/A | |
Total Assets | 2.1M +150.54% | 855,977 -98.87% | 75.7M +28.72% | 58.8M N/A | |
Income Taxes Payable | 18,845 N/A | N/A N/A | 4.4M +39.06% | 3.2M N/A | |
Total Short-Term Debt | 1.0M N/A | N/A N/A | 630,292 -64.87% | 1.8M N/A | |
Total Current Liabilities | 2.3M +5,174.52% | 43,231 -99.75% | 17.6M +49.71% | 11.8M N/A | |
Total Long-Term Debt | 24,950 N/A | N/A N/A | 616,955 +2.73% | 600,537 N/A | |
Total Long-Term Liabilities | 28,227 N/A | N/A N/A | 8.0M +26.26% | 6.3M N/A | |
Total Liabilities | 2.3M +5,061.50% | 44,661 -99.90% | 42.6M +42.14% | 30.0M N/A | |
Retained Earnings | -3.4M -85.48% | -23.7M +1,162.76% | -1.9M -54.32% | -4.1M N/A | |
Total Stockholders Equity | -137,406 -116.94% | 811,316 -96.32% | 22.1M +15.92% | 19.0M N/A | |
Total Shares Outstanding | 82.6M +41.51% | 58.4M +213.32% | 18.6M +2.09% | 18.2M N/A | |
Cash Flow | |||||
Cash from Operating Activities | 516,724 -83.15% | 3.1M -62.75% | 8.2M -22.64% | 10.6M N/A | |
Capital Expenditures | 1,484 -96.68% | 44,644 -98.06% | 2.3M -72.13% | 8.3M N/A | |
Cash from Investing Activities | 18,885 +100.67% | -2.8M -48.59% | -5.5M -33.50% | -8.3M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -568,365 -23.01% | -738,241 -73.62% | -2.8M -18.43% | -3.4M N/A | |
Financials Ratio | |||||
Gross Margin | 13.95% +103.82% | -365.49% -4,054.15% | 9.24% -41.00% | 15.67% N/A | |
Operating Margin | -5.45% -98.51% | -365.49% -4,054.15% | 9.24% -41.00% | 15.67% N/A | |
Return on Assets | -5.39% -93.88% | -88.10% -1,957.95% | 4.74% -2.27% | 4.85% N/A | |
Return on Equity | -24.01% -91.85% | -294.78% -1,999.85% | 15.52% -1.96% | 15.83% N/A | |
Revenue Growth | 3,782.57% +3,890.19% | -99.80% -510.30% | 24.32% +80.38% | 13.48% N/A | |
Current Ratio | 0.80 -95.65% | 18.48 +2,245.30% | 0.79 +17.56% | 0.67 N/A | |
Cash Ratio | 0.05 -96.18% | 1.36 +2,689.92% | 0.05 -32.41% | 0.07 N/A | |
Debt-to-Equity Ratio | -7.47 N/A | N/A N/A | 0.06 -55.09% | 0.13 N/A | |
Debt-to-Assets Ratio | 0.48 N/A | N/A N/A | 0.02 -59.46% | 0.04 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow